05/09/2024
4:04 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:15 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form ARS | |
04/09/2024
3:30 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:42 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:29 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:33 PM | Cohen Darrel P. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:36 PM | Rothera Mark (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Read this before you buy AI stocks (Ad) BREAKING: New "Formula" Could Lead to Huge AI Payouts
When you click here and see what Elon Musk's new invention does…
Investors — including multiple billionaires — are now tapping into a unique AI secret to pocket huge, consistent payouts. Starting today, you could siphon a new stream of income from this $3 billion pool of cash. |
03/07/2024
4:04 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2024
7:40 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
6:56 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:58 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/27/2024
6:54 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
8:04 PM | FORWARD VENTURES V LP (Filed by)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form SC 13G | |
11/28/2023
6:01 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
6:03 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/28/2023
6:06 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
4:30 PM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:30 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/04/2023
6:01 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/29/2023
5:49 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:52 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2023
5:47 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:46 PM | Cohen Darrel P. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
3:51 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
4:58 PM | Cohen Darrel P. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/14/2023
7:02 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2023
6:36 AM | Viracta Therapeutics, Inc. (Filer)
Viracta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2023
5:34 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:41 PM | Rubino Stephen (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:49 PM | Simon Barry J. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:11 PM | Barlow Jane F (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:13 PM | Borellini Flavia (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:19 PM | Chung Jane (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:22 PM | DARCY THOMAS E (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:26 PM | Murphy Samuel Lafayette (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
5:28 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
6:29 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
6:30 PM | Pomerantz Roger (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
6:32 PM | ROYSTON IVOR (Reporting)
Viracta Therapeutics, Inc. (Issuer)
Viracta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/26/2023
5:01 PM | Chevallard Daniel R. (Reporting)
Viracta Therapeutics, Inc. (Subject)
Viracta Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
